In a mouse model, the same researchers demonstrated how SOX11 expression promoted MCL cell migration and, consequently, the organ dissemination of tumor cells, with all events decreasing following treatment with the FAK inhibitor PF-573228 (30 mg/kg for 28 days) (57). This evidence concerns the gene PTK2 and neoplasm.